---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-041361"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T17:12:42.104894+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q2 net income $823k on non-cash gain; revenue down 64% to $1.39M

## Summary
- Q2 2023 revenue $1.389M vs $3.858M in Q2 2022, down 64% due to exit of grain and body care sales.
- Net income $823k ($0.61/share) vs net loss $3.777M ($6.81 loss) in prior year; includes $4.4M non-cash warrant gain.
- Exiting Body Care brands ProVault and SoulSpring; expects $2M OpEx savings in H2 2023, $3-4M annual.
- Engaged Lake Street Capital Markets to explore strategic options including sale, merger, or capital raise.
- GoodWheat launches pancake & waffle mixes; Zola coconut water adds hundreds of retail stores in Q2.

## SEC filing metadata
- accession: 0000950170-23-041361
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017023041361/0000950170-23-041361-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017023041361/rkda-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-041361
- JSON: https://secwatch.observer/filing/0000950170-23-041361.json
- Plain text: https://secwatch.observer/filing/0000950170-23-041361.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.